Peter Sebo got a PhD. (CSc.) in microbiology in 1990 in Prague and did his postdoc at Institut Pasteur in Paris (1990-95). Since 1995, he heads a lab at the Institute of Microbiology of the Czech Academy of Sciences (CAS) in Prague. He also founded the Institute of Biotechnology of the CAS and designed the BIOCEV research center in Vestec and also serves as professor of microbiology at the University of Chemistry and Technology in Prague. Peter Sebo's research focuses on bacterial pathogenesis and the mechanisms of Bordetella pertussis virulence and toxin action. Prof. Sebo is involved in therapeutic and prophylactic vaccine development, published over 165 papers (H=43) and was elected to EMBO and the European Academy of Microbiology. 

Seminar topic: Why is whooping cough a problem again and how it works